Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Effect Analysis of Different Regimens of Capecitabine in the Treatment of Patients With Advanced Colon Cancer

NCT06246461 is registered in ClinicalTrials.gov with Jingjiang People's Hospital as lead sponsor.

NCT NCT06246461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06246461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Effect Analysis of Different Regimens of Capecitabine in the Treatment of Patients With Advanced Colon Cancer
Lead sponsor
Jingjiang People's Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2022
Completion date
January 22, 2024
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

capecitabine